The regulatory framework for implanted medical devices is preventing severely impaired people from benefitting from rehabilitation research. Consequently, research effort is wasted and we are unable to use implants to reduce the costs of healthcare. The framework should be altered so that it is economically possible to get new devices for small patient groups into widespread use.
HamidRLovemanCMillenJet al. Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspective. Pharmacoeconomics2015; 33: 381–393.
2.
BrindleyGS. The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia1994; 32: 795–805.
3.
KirkhamAPKnightSLCraggsMDet al. Neuromodulation through sacral nerve roots 2 to 4 with a Finetech-Brindley sacral posterior and anterior root stimulator. Spinal Cord2002; 40(6): 272–282.
4.
TaiCFRoppoloJRde GroatWC. Block of external urethral sphincter contraction by high frequency electrical stimulation of pudendal nerve. J Urol2004; 172(5): 2069–2072.
5.
BhadraNBhadraNKilgoreK. High frequency electrical conduction block of the pudendal nerve. J Neural Eng2006; 3(2): 180–186.
6.
KilgoreKBhadraN. Reversible nerve conduction block using kilohertz frequency alternating current. Neuromodulation2014; 17(3): 242–255.
7.
MetcalfeBWNielsenTNDonaldsonNNet al. First demonstration of velocity selective recording from the pig vagus using a nerve cuff shows respiration afferents. Biomed Eng Lett. submitted.
8.
DemarchiJ. IMPRESS workshop, Leeds, 2014.
9.
Bailey-WoodS. BSI Standards Outlook 2016. Kolkata, India: BSI, 2016.
